PMC8138147_01
Postinjection tenonitis and conjunctivitis. Purulent infiltration of the injection site with surrounding conjunctival injection 3 days following IVI with bevacizumab. IVI, intravitreal injection.
cop-0012-0311-g01.jpg
PMC8138147_01_cop-0012-0311-g01.jpg
F1
Slit-lamp examination showed a white infiltrate at the injection site and conjunctival injection at and around the injection site in the left eye (shown in Fig. 1).